Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
Executive search firm Slone Partners has placed Roger Moody as chief financial officer of Clinical Genomics. Mr. Moody will direct all strategic and tactical financial operations for the biotechnology business. His extensive experience in managing rapid growth and delivering for investors will be instrumental in achieving Clinical Genomics’ expansion objectives, the company said. “We are thrilled to
Executive search firm Slone Partners has created a corporate Western division and related expansion activities throughout California. The strategic initiative, overseen by Slone Partners president Tara Kochis-Stach, is designed to better allow the firm to service dozens of California-based clients, develop relationships with next generation start-ups, and capitalize on California’s continued growth as a healthcare innovation
Healthcare is among the most rapidly growing employment fields, according to analysts at Hunt Scanlon Media, which tracks trends in the executive search and leadership solutions space. This has led to an increased need for recruiting firms to deliver top drawer leaders throughout the sector. Executive search firm Slone Partners recently placed CEOs at Avomeen Analytical Services
Executive search firm Slone Partners has placed Dr. Michael Dugan as chief medical officer of Clinical Genomics. Dr. Dugan is a well known biotechnology leader with extensive clinical experience in both commercial and academic settings. In his new role, Dr. Dugan will lead medical affairs and clinical trials, develop key opinion leader relationships, and build a scientific advisory board.
Thought Leadership
Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders
What’s Next in Precision Medicine: Leadership Challenges and Opportunities
Full-Time vs. Fractional Talent: What’s the Best Fit for Your Organization?
Fractional Talent On Demand: The Slone Partners Difference
Life Sciences Leadership, Redefined: What Boards are Looking for in 2025